| http://www.w3.org/ns/prov#value | - Blue chips to look out for include the three biggest US-based biotech companies, Amgen, Gilead Sciences and Celgene, which are focused on developing medicine to address catastrophic illnesses such as cancer and human immunodeficiency virus (HIV)/AIDS. Amgen The industry leader Amgen (AMGN) has a market cap of $86.32 billion as of April 2014, 18,000 employees and sales at $17.27 billion.
|
